G Bastert
Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study
Schneeweiss A, Wallwiener D, Hamerla R, Solomayer E, Krauss K, Beldermann F, Rudlowski C, von Fournier D, Sinn H, Huober J, Bastert G. Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study. European journal of cancer (Oxford, England : 1990) 2004; 40:2432-8.
Nov 1, 2004Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study
Nov 1, 2004European journal of cancer (Oxford, England : 1990) 2004; 40:2432-8
Schneeweiss A, Wallwiener D, Hamerla R, Solomayer E, Krauss K, Beldermann F, Rudlowski C, von Fournier D, Sinn H-P, Huober Jens, Bastert G
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
Colleoni M, Collins J, Thürlimann B, Holmberg S, Crivellari D, Beyerle C, Neumann R, Goldhirsch A, International Breast Cancer Study Group, Lindtner J, Schmoor C, Rudenstam C, Litman H, Castiglione-Gertsch M, Sauerbrei W, Gelber R, Bonetti M, Coates A, Schumacher M, Bastert G, German Breast Cancer Study Group. Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF. British journal of cancer 2002; 86:1705-14.
Jun 5, 2002Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
Jun 5, 2002British journal of cancer 2002; 86:1705-14
Colleoni M, Collins J, Thürlimann Beat, Holmberg S B, Crivellari D, Beyerle C, Neumann R L A, Goldhirsch A, International Breast Cancer Study Group, Lindtner J, Schmoor C, Rudenstam C-M, Litman H J, Castiglione-Gertsch M, Sauerbrei W, Gelber R D, Bonetti M, Coates A S, Schumacher M, Bastert G, German Breast Cancer Study Group
Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
Hohaus S, Wallwiener D, Martin S, Voso M, Huober J, Fersis N, Bastert G, Haas R. Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer. Seminars in oncology 1998; 25:7-11; discussion 45-8.
Apr 1, 1998Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
Apr 1, 1998Seminars in oncology 1998; 25:7-11; discussion 45-8
Hohaus S, Wallwiener D, Martin S, Voso M T, Huober Jens, Fersis N, Bastert G, Haas R
Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
Huober J, Haas R, Bastert G, Goldschmidt H, Martin S, Meyer A, Wittmann G, Hohaus S, Schneeweiss A, Wallwiener D. Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer. Journal of cancer research and clinical oncology 1998; 124:690-4.
Jan 1, 1998Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer
Jan 1, 1998Journal of cancer research and clinical oncology 1998; 124:690-4
Huober Jens, Haas R, Bastert G, Goldschmidt H, Martin S, Meyer A, Wittmann G, Hohaus S, Schneeweiss A, Wallwiener D
[Paraneoplastic retinopathy in 2 patients with breast carcinoma]
Huober J, Holz F, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G. [Paraneoplastic retinopathy in 2 patients with breast carcinoma]. Zentralblatt für Gynäkologie 1997; 119:278-81.
Jan 1, 1997[Paraneoplastic retinopathy in 2 patients with breast carcinoma]
Jan 1, 1997Zentralblatt für Gynäkologie 1997; 119:278-81
Huober Jens, Holz F G, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G
Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters
Hamann U, Costa S, Goette K, Huober J, Solomayer E, Kaufmann M, Bastert G, Komitowski D. Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters. The Breast 1997; 6:5.
Jan 1, 1997Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters
Jan 1, 1997The Breast 1997; 6:5
Hamann U, Costa SD, Goette K, Huober Jens, Solomayer EF, Kaufmann M, Bastert G, Komitowski D
Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta
Huober J, Grischke E, Hahn U, Wallwiener D, Bastert G. Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta. Gynäkolo. prax 1997; 21:685-689.
Jan 1, 1997Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta
Jan 1, 1997Gynäkolo. prax 1997; 21:685-689
Huober Jens, Grischke E-M, Hahn U, Wallwiener D, Bastert G
[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]
Huober J, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]. Geburtshilfe und Frauenheilkunde 1996; 56:214-6.
Apr 1, 1996[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]
Apr 1, 1996Geburtshilfe und Frauenheilkunde 1996; 56:214-6
Huober Jens, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G
[Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]
Huober J, Sprenger H, Costa S, Zentgraf H, Schmid H, Kaufmann M, Bastert G. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]. Zentralblatt für Gynäkologie 1996; 118:560-4.
Jan 1, 1996[Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]
Jan 1, 1996Zentralblatt für Gynäkologie 1996; 118:560-4
Huober Jens, Sprenger H, Costa S D, Zentgraf H, Schmid H, Kaufmann M, Bastert G
[Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]
Mende U, Huober J, Schmid H, Winterbauer T, Bastert G, Wannenmacher M. [Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]. Der Radiologe 1996; 36:22-30.
Jan 1, 1996[Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]
Jan 1, 1996Der Radiologe 1996; 36:22-30
Mende U, Huober Jens, Schmid H, Winterbauer T, Bastert G, Wannenmacher M
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]
Sinn H, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto H. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. Geburtshilfe und Frauenheilkunde 1994; 54:552-8.
Oct 1, 1994[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]
Oct 1, 1994Geburtshilfe und Frauenheilkunde 1994; 54:552-8
Sinn H P, Schmid H, Junkermann H, Huober Jens, Leppien G, Kaufmann M, Bastert G, Otto H F
Klinisch relevante Prognosefaktoren beim Mammakarzinom
Costa S, von Minkwitz G, Gremm B, Huober J, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel I, Kaufmann M, Bastert G. Klinisch relevante Prognosefaktoren beim Mammakarzinom. Klin Lab 1994; 40:1153-1166.
Jan 1, 1994Klinisch relevante Prognosefaktoren beim Mammakarzinom
Jan 1, 1994Klin Lab 1994; 40:1153-1166
Costa SD, von Minkwitz G, Gremm B, Huober Jens, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel IJ, Kaufmann M, Bastert G